Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nina Turnsek Hitij"'
Autor:
Lea Knez, Matjaž Zwitter, Aleksander Sadikov, Tanja Cufer, Izidor Kern, Karmen Stanic, Nina Turnsek Hitij
Publikováno v:
Clinical Lung Cancer. 18:e187-e196
Introduction The sensitivity and specificity of immunohistochemistry (IHC) was compared with the standard polymerase chain reaction (PCR)-based method for detecting common activating epidermal growth factor receptor ( EGFR ) mutations in non–small-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3affa3f11113baf56f3601d213580ccc
https://doi.org/10.1016/j.cllc.2016.11.021
https://doi.org/10.1016/j.cllc.2016.11.021
Autor:
Matjaz Zwitter, Izidor Kern, Tanja Cufer, Nina Turnsek Hitij, Karmen Stanic, Aleksander Sadikov
Publikováno v:
Radiology and Oncology
Radiology and oncology (Ljubljana)
Radiology and oncology (Ljubljana)
Background. The brain represents a frequent progression site in lung adenocarcinoma. This study was designed to analyse the association between the epidermal growth factor receptor (EGFR) mutation status and the frequency of brain metastases (BM) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0137904ea1e72a2abe69752be283033
http://europepmc.org/articles/PMC4078036
http://europepmc.org/articles/PMC4078036
Publikováno v:
Journal of Thoracic Oncology. 12:S388-S389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71d2af483a10e2eeec5cf1d7d10ec14c
https://doi.org/10.1016/j.jtho.2016.11.440
https://doi.org/10.1016/j.jtho.2016.11.440
Publikováno v:
Annals of Oncology. 23:ix523-ix524
Background Anemia is common in patients with lung cancer. The aim of our analysis was to establish the rate and severity of anemia in a collective of advanced lung cancer and mesothelioma patients, treated with chemotherapy in a routine clinical prac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca91855cb379b918c83ccac19319c68f
https://doi.org/10.1016/s0923-7534(20)34181-8
https://doi.org/10.1016/s0923-7534(20)34181-8
Publikováno v:
Annals of Oncology. 23:ix522
Background Febrile neutropenia (FN) is a serious complication of chemotherapy (ChT). Lung cancer patients are fragile with much comorbidity mostly receiving intermediate FN (iFN) risk ChT schemas and primary prophylaxis with granulocyte colony-stimul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28b9c2b275478ff1a00de424a190cdfe
https://doi.org/10.1016/s0923-7534(20)34176-4
https://doi.org/10.1016/s0923-7534(20)34176-4